Clinical Trials Browser

Phase 2 × Completed × Carcinoma, Endometrioid × Clear all

NCT01935934 2025-10-01

Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

Phase 2 Completed

102 enrolled 14 charts

Carcinoma, Endometrioid

NCT02728258 2022-02-15

Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Phase 2 Completed

11 enrolled 12 charts

Carcinoma, Endometrioid

NCT02093598 2020-11-27

POEM

Phase 2 Completed

Carcinoma, Endometrioid